The tumor necrosis factor signaling complex: Choosing a path toward cell death or cell proliferation

Leukemia and Lymphoma

Volumn 29, Issue 1-2, 1998, Pages 81-92

  Warzocha, Krzysztof ^a   Salles, Gilles ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Apoptosis; Death domain; Lymphotoxin; Proliferation; TNF; TRAF

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CELL PROLIFERATION; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031833240     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058384     Document Type: Review

References (94)

1. Beutler, B. (1992). Tumor necrosis factors: the molecules and their emerging role in medecine, New York: Raven Press.
2. Gruss, H. J. and Dower, S. K. (1995). Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85, 3378-3404.
3. Warzocha, K., Salles, G., Bienvenu, J., Bastion, Y., Dumontet, C., Renard, N., Neidhardt, E. M. and Coiffier, B. (1997). The tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. Journal of Clinical Oncology, 15, 499-508.
4. Bazzoni, F. and Beutler, B. (1996). The tumor necrosis factor ligand and receptor families. New England Journal of Medicine, 334, 1717-1725.
5. Warzocha, K., Bienvenu, J., Coiffier, B. and Salles, G. (1995) Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. European Cytokine Network, 6, 83-96.
6. Chinnaiyan, A. M., O'Rourke, K., Yu, G. L., Lyons, R. H., Garg, M., Duan, R., Xing, L., Gentz, R., Ni, J. and Dixit, V. M. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR-I and CD95. Science, 274, 990-992.
7. Kitson, J., Raven, T., Jiang, Y. P., Goeddel, D. V., Giles, K. M., Pun, K. T., Grinham, C. J., Brown, R. and Farrow, S. N. (1996) A death-domain-containing receptor that mediates apoptosis. Nature, 384, 372-375.
8. Jelinek, D. F. and Lipsky, P. E. (1987) Enhancement of human B-cell proliferation and differentiation by tumor necrosis factor alpha and interleukin-1. Journal of Immunology, 139, 2970-2975.
9. Tartalgia, L. A., Goeddel, D. V., Reynolds, C., Figari, I. S., Weber, R. F., Fendly, B. M. and Palladino, M. A. (1993) Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. Journal of Immunology, 151, 4637-4641.
10. Ranges, G. E., Zlotnik, A., Espevik, T., Dinarello, C. A., Cerami, A. and Palladino, M. A. (1988) Tumor necrosis factor/cachectin is a growth factor for thymocytes. synergistic interactions with other cytokines. Journal of Experimental Medicine, 167, 1472-1477.
11. Caux, C., Dezutter-Dambuyant, C., Schmitt, D. and Banchereau, J. (1992) GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature, 360, 258-261.
12. Macchia, D., Almerigogna, F., Parronchi, P., Ravina, A., Maggi, E. and Romagnani, S. (1993). Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T-cells. Nature, 363, 464-466.
13. Cordingley, F. T., Hoffbrand, A. V., Heslop, H. E., Turner, M., Bianchi, A., Reittie, J. E., Vyakarnam, A., Meager, A. and Brenner, M. K. (1988). Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet, I, 969-971.
14. Brailly, H., Pebusque, M. J., Tabilio, A. and Mannoni, P. (1993). TNF alpha acts in synergy with GM-CSF to induce proliferation of acute myeloid leukemia cells by upregulation the GM-CSF receptor and GM-CSF gene expression. Leukemia, 7, 1557-1563.
15. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F. and Lynch, D. H. (1993). Fas transduces activation signals in normal human T-lymphocytes. Journal of Experimental Medicine, 178, 2231-2235.
16. Mapara, M. Y., Bargou, R., Zugck, C., Doehner, H., Ustaoglu, F., Jonker, R. R., Krammer, P. H. and Dorken, B. (1993). APO-1 mediated apoptosis or proliferation in human chronic B-lymphocytic leukemia: correlation with bcl-2 oncogene expression. European Journal of Immunology, 23, 702-708.
17. Kehrl, J. H., Alvarez-Mon, M., Delsing, G. A. and Fauci, A. S. (1987). Lymphotoxin is an important T-cell derived growth factor for human B-cells. Science, 238, 1144-1148.
18. Lee, S. Y., Park, C. G. and Choi, Y. (1996). T cell receptor-dependent cell death of T-cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. Journal of Experimental Medicine, 183, 669-674.
19. Smith, C. A., Farrah, T. and Goodwin, R. G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell, 76, 959-962.
20. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. and Goodwin, R. G. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-682.
21. Androlewicz, M. J., Browning, J. L. and Ware, C. F. (1992). Lymphotoxin is expressed as a heteromeric complex with a distinct 33 kDa glycoprotein on the surface of an activated human T-cell hybridoma. Journal of Biological Chemistry, 267, 2542-2547.
22. Kriegler, M., Perez, C. C., DeFay, K., Albert, I. and Lu, D. (1988). A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell, 53, 45-53.
23. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J. and Cerretti, D. P. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature, 385, 729-733.
24. Moss, M. L., Jin, S. L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Moyers, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J. L., Warner, J., Willard, D. and Becherer, J. D. (1997). Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature, 385, 733-736.
25. Nedwin, G. E., Naylor, S. L., Sakaguchi, A. Y., Smith, D., Jarret-Nedwin, J., Pennica, D., Hayflick, J. S., Goeddel, D. V. and Gray, P. W. (1985). Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Research, 13, 6361-6373.
26. Browning, J. T., Ngam-ek, A., Lawton, P., DeMarinis, J., Tizard, R., Chow, E. P., Hession, C., O'Brine-Greco, B., Foley, S. F. and Ware, C. F. (1993). Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell, 72, 847-856.
27. Browning, J. L., Miatkowski, K., Griffiths, D., Bourdon, P. R., Hession, C., Ambrose, C. M. and Meier, W. (1996). Preparation and characterization of soluble recombinant heteromeric complexes of human lymphotoxin α and β. Journal of Biological Chemistry, 271, 8618-8626.
28. Browning, J. L., Androlewicz, M. J. and Ware, C. F. (1991). Lymphotoxin and an associated 33 kDa glycoprotein are expressed on the surface of an activated human T-cell hybridoma. Journal of Immunology, 147, 1230-1237.
29. Browning, J. L., Dougas, I., Ngam-ek, A., Bourdon, P. R., Ehrenfels, B. N., Miatkowski, K., Zafari, M., Yampaglia, A. M., Lawton, P., Meier, W., Benjamin, C. P. and Hession, C. (1995). Characterization of surface lymphotoxin forms. Journal of Immunology, 154, 33-46.
30. Loetscher, H., Pan, Y. C. E., Lahm, H. W., Gentz, R., Brockhaus, M., Tabuchi, H. and Lesslauer, W. (1990). Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell, 61, 351-359.
31. Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H., W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., Kohr, W. J. and Goeddel, D. V. (1990). Molecular cloning and expression of a receptor human tumor necrosis factor. Cell, 61, 361-370.
32. Heller, R. A., Song, K., Onasch, M. A., Fischer, W. H., Chang, D. and Ringold, G. M. (1990). Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proceedings of the National Academy of Science USA, 87, 6151-6155.
33. Sprang, S. R. and Eck, M. J. (1992). The 3-D structure of TNF. In: Tumor necrosis factors: the molecules and their emerging role in medicine, B. Beutler (ed.), pp. 11-32. (Raven Press, New York.)
34. Hohmann, H. P., Remy, R. and Brochaus, M. (1989). Two different cell types have different major receptors for human tumor necrosis factor (TNFα). Journal of Biological Chemistry, 264, 14927-14934.
35. Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Wenie, S. D., Goodwin, R. G. and Smith, C. A. (1994). A lymphotoxin-β-specific receptor. Science, 264, 707-709.
36. Baens, M., Chaffanet, M., Cassiman, J. J., Van den Berghe, H. and Marynen, P. (1993). Construction and evaluation of a hcDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics, 16, 214-218.
37. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S. I., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243.
38. Tartaglia, L. A. and Goeddel, D. V. (1992). Tumor necrosis factor receptor signaling. A dominant negative mutation supresses the activation of the 55-kDa tumor necrosis factor receptor. Journal of Biological Chemistry, 267, 4304-4307.
39. Itoh, N. and Nagata, S. (1993). A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. Journal of Biological Chemistry, 268, 10932-10937.
40. Tartaglia, L. A., Ayres, T. M., Wong, G. H. W. and Goeddel, D. V. (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell, 73, 845-853.
41. Rothe, M., Wong, S. C., Henzel, W. J. and Goeddel, D. V. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor. Cell, 78, 681-692.
42. Cheng, G., Cleary, A. M., Ye, Z. S., Hong, D. I., Lederman, S. and Baltimore, D. (1995). Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science, 267, 1494-1498.
43. Rothe, M., Sarma, V., Dixit, V. M. and Goeddel, D. V. (1995). TRAF2-mediated activation of NF-κB by TNF receptor2 and CD40. Science, 269, 1424-1427.
44. Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C. F., Yagita, H. and Okumura, K. (1996). TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. Journal of Biological Chemistry, 271, 14661-14664.
45. Ishida, T., Mizushima, S., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., Yamamoto, T. and Inoue, J. (1996). Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. Journal of Biological Chemistry, 271, 28745-28748.
46. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. and Goeddel, D. V. (1996). TRAF6 is a signal transducer for interleukin-1. Nature, 383, 443-446.
47. Aizawa, S., Nakano, H., Ishida, T., Horie, R., Nagai, M., Ito, K., Yagita, H., Okumura, K., Inoue, J. and Watanabe, T. (1997). Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFKappaB activation. Journal of Biological Chemistry, 272, 2042-2045.
48. Heaney, M. L. and Golde, D. W. (1996). Soluble cytokine receptors. Blood, 87, 847-857.
49. Aderka, D., Engelmann, H., Hornik, V., Skornick, Y., Levo, Y., Wallach, D. and Kushtar, G. (1991). Increased serum levels of soluble receptors for tumour necrosis factor in cancer patients. Cancer Research, 51, 5602-5609.
50. Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L. and Lowry, S. F. (1992). Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proceedings of the National Academy of Science USA, 89, 4845-4849.
51. Higuchi, M. and Aggarwal, B. B. (1992). Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant p60 and p80 receptors. Biochemical Biophysical Research Communications, 182, 638-643.
52. Aderka, D., Engelmann, H., Maor, Y., Brakebush, C. and Wallach, D. (1992). Stabilization of the biactivity of tumour necrosis factor by its soluble receptors. Journal of Experimental Medicine, 175, 323-329.
53. Bemelmans, M. H. A., Gouma, D. J. and Buurman, W. A. (1993). Influence of nephrectomy on tumor necrosis factor clearance in murine model. Journal of Immunology, 150, 2007-2017.
54. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H. and Lesslauer, W. (1993). Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell, 73, 431-445.
55. Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y. S., Sarov, I., Nophar, Y., Hadas, E., Leitner, O. and Wallach, D. (1990). Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. Journal of Biological Chemistry, 265, 14497-14504.
56. Heldin, C. H. (1995). Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223.
57. Boldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H. and Wallach, D. (1995). Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and FAS/APO1 effects. Journal of Biological Chemistry, 270, 387-391.
58. Tartaglia, L. A., Pennica, D. and Goeddel, D. V. (1993). Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. Journal of Biological Chemistry, 268, 18542-18548.
59. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., Dixit, V. M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
60. Hsu, H., Xiong, J. and Goeddel, D. V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell, 81, 495-504.
61. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523.
62. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76, 969-976.
63. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell, 85, 803-815.
64. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rurke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E. and Dixit, V. M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85, 817-827.
65. Wilson, K. P., Black, J. A. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A. and Livingston, D. J. (1994). Structure and mechanism of interleukin-1β-converting enzyme. Nature, 370, 270-275.
66. Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E. and Dixit, V. M. (1996). FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. Journal of Biological Chemistry, 271, 4961-4965.
67. Beidler, D. R., Tewari, M., Friesen, P. D., Poirier, G. and Dixit, V. M. (1995). The baculovirus p35 protein inhibits Fas-and tumor necrosis factor-induced apoptosis. Journal of Biological Chemistry, 270, 16526-16528.
68. Tewari, M. and Dixit, V. M. (1995). Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus Crma gene product. Journal of Biological Chemistry, 270, 3255-3260.
69. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L. and Miller, D. K. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
70. Wallach, D., Holtmann, H., Engelmann, H. and Nophar, Y. (1988). Sensitization and densitization to lethal effects of tumor necrosis factor and IL-1. Journal of Immunology, 140, 2994-2999.
71. Baeuerle, P. A. and Baltimore, D. (1996). NF-κB: ten years after. Cell, 87, 13-20.
72. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature, 376, 167-170.
73. Beg, A. A. and Baltimore, D. (1996). An essential role for NF-κB in preventing TNF-β-induced cell death. Science, 274, 782-784.
74. Wang, C. Y., Mayo, M. W. and Baldwin, A. S. (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science, 274, 784-787.
75. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M. (1996). Suppression of TNF-β-induced apoptosis by NF-κB. Science, 274, 787-789.
76. Liu, Z. G., Hsu, H., Goeddel, D. V. and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell, 87, 565-567.
77. Takeuchi, M., Rothe, M. and Goeddel, Goeddel, D. V. (1996). Anatomy of TRAF2. Distinct domains for nucelar factor-κB activation and association with tumor necrosis factor signaling proteins. Journal of Biological Chemistry, 271, 19935-19942.
78. Hsu, H., Shu, H. B., Pan, M. G. and Goeddel, D. V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor1 signal transduction pathways. Cell, 84, 299-308.
79. Ponton, A., Clement, M. V. and Stamenkovic, I. (1996). The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function. Journal of Biological Chemistry, 271, 8991-8995.
80. Malinin, N. L., Boldin, M. P., Kovalenko, A. V. and Wallach, D. (1997). MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature, 385, 540-544.
81. Seger, R. and Krebs, E. G. (1995). The MAPK signaling cascade. FASEB Journal, 9, 726-735.
82. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. and Goeddel, D. V. (1996). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4, 387-396.
83. Natoli, G., Costanzo, A., Ianni, A., Templeton, D. J., Woodgett, J. R., Balsano, C. and Levrero, M. (1997). Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science, 275, 200-203.
84. Shelton, C. A. and Wasserman, S. A. (1993). Pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo. Cell, 72, 515-525.
85. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399.
86. Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E. and Rickinson, A. B. (1994). Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. Journal of Virology, 68, 5602-5612.
87. Hay, B. A., Wassarman, D. A. and Rubin, G. M. (1995). Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death. Cell, 83, 1253-1262.
88. Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M. and Goeddel, D. V. (1995). The TNFR2-TRAF signaling complex contains two novel proteins related to baculovirus inhibitor of apoptosis proteins. Cell, 83, 1243-1252.
89. Rothe, M., Xiong, J., Shu, H. B., Williamson, K., Goddard, A. and Goeddel, D. V. (1996). I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proceedings of the National Academy of Science USA, 93, 8241-8246.
90. L function upstream of the CED-3-like apoptotic proteases. Journal of Biological Chemistry, 271, 4573-4576.
91. Fernandez, A., Marin, M. C., McDonnell, T. and Ananthaswamy, H. N. (1994). Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells. Oncogene, 9, 2009-2017.
92. Hennet, T., Bertoni, G., Richter, C. and Peterhans, E. (1993). Expression of bcl-2 proten enhances the survival of mouse fibrosarcoid cells to tumor necrosis factor-mediated cytotoxicity. Cancer Research, 53, 1456-1460.
93. Itoh, N., Tsujimoto, Y. and Nagata, S. (1993). Effect of bcl-2 on Fas antigen-mediated cell death. Journal of Immunology, 151, 621-627.
94. Iwai, K., Miyawaki, T., Takizawa, T., Konno, A., Ohta, K., Yachie, A., Seki, H. and Taniguchi, N. (1994). Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood, 84, 1201-1208.